T. Yamashita

Takuhiro Yamaguchi, Y. Nannya, I. Miura, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia

R. Suzuki, M. Imamura, K. Kumano, 2011, International journal of hematology.

Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study

K. Ozawa, M. Mori, M. Imamura, 2016, International Journal of Hematology.

Association of Cumulative Steroid Dose with Risk of Infection after Treatment for Severe Acute Graft-versus-Host Disease.

S. Fuji, S. Kurosawa, T. Fukuda, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Characterization of Late Acute and Chronic Graft-Versus-Host Disease according to the 2014 National Institutes of Health Consensus Criteria in Japanese Patients.

S. Fuji, Y. Inoue, S. Kurosawa, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

MmTRA1b/phospholipid scramblase 1 gene expression is a new prognostic factor for acute myelogenous leukemia.

S. Tomoyasu, T. Nakamaki, A. Yokoyama, 2004, Leukemia research.

A Case Report of Thrombotic Thrombocytopenic Purpura and Severe Acute Renal Failure Post Non‐myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation Treated With Plasma Exchange and Hemodialysis

H. Sakamaki, E. Kanda, Hitoe Suzuki, 2007, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Fatal intracranial hemorrhage following administration of recombinant thrombomodulin in a patient after cord blood transplantation

M. Tsubokura, M. Kami, T. Ikezoe, 2011, Bone Marrow Transplantation.

Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study

Y. Kodera, R. Ueda, M. Kami, 2009, Bone Marrow Transplantation.

High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation.

H. Ogawa, K. Ohashi, K. Miyamura, 2019, Blood advances.

Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation.

Y. Kanda, C. Nakaseko, H. Sakamaki, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Feasibility of reduced-intensity cord blood transplantation as salvage therapy for graft failure: results of a nationwide survey of adult patients.

M. Taniwaki, Y. Kanda, A. Utsunomiya, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

t(11;14)(q23;q24) generates an MLL-human gephyrin fusion gene along with a de facto truncated MLL in acute monoblastic leukemia.

K. Motoyoshi, F. Kimura, T. Yamashita, 2001, Cancer research.

Monoblastic Leukemia in Acute MLL Truncated de facto Gene along with a Fusion Gephyrin-Human MLL t ( 11 ; 14 ) ( q 23 ; q 24 ) Generates an Updated

K. Motoyoshi, F. Kimura, T. Yamashita, 2001 .

Meningeal hematopoiesis following radiation myelitis in a hematopoietic stem‐cell transplant recipient

N. Kamata, K. Ohashi, H. Sakamaki, 2005, American journal of hematology.

An autopsy case that manifested no convincing histological changes of severe renal failure after hematopoietic stem cell transplantation

M. Tsubokura, H. Sakamaki, H. Akiyama, 2014, CEN Case Reports.

Impact of chronic GVHD on QOL assessed by visual analogue scale in pediatric HSCT survivors and differences between raters: a cross-sectional observational study in Japan

Y. Kanda, S. Adachi, K. Kamibeppu, 2021, International Journal of Hematology.

Rapidly progressive Epstein-Barr virus-associated lymphoproliferative disorder unpredictable by weekly viral load monitoring.

K. Ohashi, H. Sakamaki, H. Akiyama, 2010, Internal medicine.

Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation.

S. Fuji, S. Kurosawa, T. Fukuda, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopo

Motohiro Kato, S. Adachi, Y. Kawano, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Incidence, risk factors, and clinical outcomes of cataracts following hematopoietic stem cell transplantation

K. Ohashi, H. Sakamaki, Y. Najima, 2011, American journal of hematology.

Late Mortality and Causes of Death among Long-Term Survivors after Allogeneic Stem Cell Transplantation.

H. Nakasone, K. Ohashi, H. Sakamaki, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study

K. Kamibeppu, Y. Ishida, Y. Atsuta, 2021, International Journal of Hematology.

Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey

Y. Kanda, Takuhiro Yamaguchi, M. Onizuka, 2018, Bone Marrow Transplantation.

Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.

K. Kawa, Y. Kodera, R. Suzuki, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation

T. Tanaka, Y. Tanaka, S. Fuji, 2016, Bone Marrow Transplantation.

Safety and efficacy of foscarnet for preemptive therapy against cytomegalovirus reactivation after unrelated cord blood transplantation.

S. Nakao, A. Takami, T. Yamashita, 2007, Transplantation proceedings.

Cloning and Characterization of a Novel RING-B-box-Coiled-coil Protein with Apoptotic Function*

S. Suzu, K. Motoyoshi, F. Kimura, 2003, Journal of Biological Chemistry.

Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT

C. Nakaseko, H. Sakamaki, S. Okamoto, 2009, Bone Marrow Transplantation.

Dual rearrangement of immunoglobulin and T-cell receptor genes in a case of Philadelphia chromosome-positive acute leukemia.

N. Nagata, K. Motoyoshi, F. Kimura, 1998, Japanese journal of clinical oncology.

Interleukin‐10 differently regulates monocyte chemoattractant protein‐1 gene expression depending on the environment in a human monoblastic cell line, UG3

K. Motoyoshi, K. Hatake, F. Kimura, 2002, Journal of leukocyte biology.

Myeloablative intravenous busulfan-containing regimens for allo-HSCT in AML or MDS patients over 54 years old: combined results of three phase II studies

K. Akashi, T. Miyamoto, M. Harada, 2020, International journal of hematology.

Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma.

S. Asano, A. Tojo, K. Tani, 2001, Haematologica.

Immature platelet fraction for prediction of platelet engraftment after allogeneic stem cell transplantation

S. Nakao, A. Takami, T. Yoshida, 2007, Bone Marrow Transplantation.

A randomized controlled trial of plasma real-time PCR and antigenemia assay for monitoring CMV infection after unrelated BMT

K. Akashi, Y. Kanda, M. Harada, 2010, Bone Marrow Transplantation.

Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation

K. Ohashi, H. Sakamaki, Y. Najima, 2009, American journal of hematology.

Specificity of polymerase chain reaction‐based clonality analysis of immunoglobulin heavy chain gene rearrangement for the detection of bone marrow infiltrate in B‐cell lymphoma‐associated haemophagocytic syndrome

M. Tanimoto, K. Kojima, M. Yasukawa, 2002, British journal of haematology.

A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease

K. Ohashi, H. Sakamaki, T. Sawada, 2010, International journal of hematology.

Reduced-intensity conditioning regimen with low-dose ATG-F for unrelated bone marrow transplant is associated with lower non-relapse mortality than a regimen with low-dose TBI: a single-center retrospective analysis of 103 cases

Y. Heike, S. Fuji, N. Hiramoto, 2013, International Journal of Hematology.

Second Allogeneic Transplantation for Relapsed Acute Leukemia after Initial Allogeneic Hematopoietic Stem Cell Transplantation

K. Ohashi, H. Sakamaki, H. Akiyama, 2012, Pathology & Oncology Research.

Y. Kodera, R. Suzuki, M. Hino, 2020, International Journal of Hematology.

Mortality and medical morbidity beyond 2 years after allogeneic hematopoietic stem cell transplantation: experience at a single institution

K. Ohashi, H. Sakamaki, T. Sawada, 2011, International journal of hematology.

Donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene: detailed immunological function following add-back after haplo-identical transplantation.

Y. Heike, J. Mineno, I. Nukaya, 2015, Cytotherapy.

The combination of paclitaxel and carboplatin as second-line chemotherapy can be a preferred regimen for patients with urothelial carcinoma after the failure of gemcitabine and cisplatin chemotherapy.

Motonobu Nakamura, K. Taguchi, M. Shimokawa, 2017, Molecular and clinical oncology.

Impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation

S. Fuji, Kodai Kuriyama, Y. Inoue, 2016, International Journal of Hematology.

A prospective multicenter study of unrelated bone marrow transplants using a reduced-intensity conditioning regimen with low-dose ATG-F

K. Ohashi, M. Hidaka, S. Fuji, 2016, Bone Marrow Transplantation.

Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia harboring trisomy 8

H. Ogawa, K. Ohashi, C. Nakaseko, 2017, Annals of Hematology.

Immunogenicity of three versus four doses of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in allogeneic haematopoietic stem cell transplantation recipients: a multicentre, randomized controlled trial.

K. Oishi, S. Fuji, K. Koh, 2022, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Clinical impact of hyperglycemia on days 0–7 after allogeneic stem cell transplantation

T. Tanaka, Y. Tanaka, S. Fuji, 2017, Bone Marrow Transplantation.

Prognosis of acute myeloid leukemia harboring monosomal karyotype in patients treated with or without allogeneic hematopoietic cell transplantation after achieving complete remission

Takuhiro Yamaguchi, N. Emi, Masato Watanabe, 2012, Haematologica.

Feasibility and usefulness of recommended screenings at long-term follow-up clinics for hematopoietic cell transplant survivors

Takuhiro Yamaguchi, T. Ueno, S. Fuji, 2021, Supportive Care in Cancer.

Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life.

Y. Kanda, Takuhiro Yamaguchi, K. Miyamura, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increased incidence of oral and gastrointestinal secondary cancer after allogeneic hematopoietic stem cell transplantation

T. Tanaka, Y. Tanaka, S. Fuji, 2017, Bone Marrow Transplantation.

Long-term follow-up system after allogeneic hematopoietic stem cell transplantation: a single-center feasibility study

Takuhiro Yamaguchi, S. Fuji, S. Kurosawa, 2014 .

Immune-Mediated Myelopathy following Allogeneic Stem Cell Transplantation

N. Kamata, K. Ohashi, H. Sakamaki, 2006, International journal of hematology.

Prognostic impact of pre-transplant quality of life and its post-transplant longitudinal change after allogeneic hematopoietic cell transplantation: a prospective study that administered SF-12 and EQ-5D.

Takuhiro Yamaguchi, S. Fuji, S. Kurosawa, 2021, Transplantation and cellular therapy.

Cross-Sectional Patient Survey on the Need for a Long-Term Follow-up Program after Autologous Hematopoietic Cell Transplantation

K. Tobinai, D. Maruyama, S. Fuji, 2016 .

Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.

Y. Kanda, Takuhiro Yamaguchi, K. Miyamura, 2017, Biology of Blood and Marrow Transplantation.

Clinical Outcomes after Allogeneic Stem Cell Transplantation for Adult Lymphoblastic Lymphoma.

K. Tobinai, S. Fuji, Y. Inoue, 2016, Journal of clinical and experimental hematopathology : JCEH.

Burkitt's acute lymphoblastic leukaemia transformatation after myelodysplastic syndrome

K. Motoyoshi, F. Kimura, T. Yamashita, 2001, British journal of haematology.

Long-Term survivor of ruptured hepatocellular carcinoma after two hepatic resections

A. Ikoma, G. Yotsumoto, T. Yamashita, 1994 .

Pharmacokinetics for once-daily modified release formulation of tacrolimus hydrate in unrelated hematopoietic stem cell transplantation

T. Machishima, Kazuhito Suzuki, S. Mori, 2015, Annals of Hematology.

Cytogenetic Abnormalities without Evidence of Relapse after Treatment with Imatinib and Stem Cell Transplantation in a Patient with Ph-Positive ALL

K. Ohashi, H. Sakamaki, H. Akiyama, 2005, International journal of hematology.

Incapacitating lower limb pain syndrome in cord blood stem cell transplant recipients with calcineurin inhibitor

K. Ohashi, H. Sakamaki, H. Akiyama, 2009, Pathology Oncology Research.

Karnofsky performance status and visual analogue scale scores are simple indicators for quality of life in long-term AYA survivors who received allogeneic hematopoietic stem cells transplantation in childhood

Y. Kanda, K. Kamibeppu, Y. Ishida, 2022, International Journal of Hematology.

Prognostic factors in patients with relapsed or refractory diffuse large B-cell lymphoma who underwent autologous stem-cell transplantation

K. Tobinai, D. Maruyama, H. Taniguchi, 2016 .

Granulocyte Colony-Stimulating Factor-Primed Donor Lymphocyte Infusion after Salvage Chemotherapy for Treatment of Relapsed Acute Leukemia after Allogeneic Stem Cell Transplantation

K. Ohashi, H. Sakamaki, K. Hiruma, 2005, International journal of hematology.

Multiple myeloma with multiple and bulky extramedullary plasmacytomas as initial presentation.

K. Ohashi, H. Sakamaki, Y. Najima, 2009, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Progression-free survival of first-line treatment with molecular-targeted therapy may be a meaningful intermediate endpoint for overall survival in patients with metastatic renal cell carcinoma.

Motonobu Nakamura, K. Taguchi, M. Shimokawa, 2017, Molecular and clinical oncology.

Cystatin C Level as a Marker of Renal Function in Hematopoietic Stem Cell Transplantation

K. Ohashi, H. Sakamaki, H. Akiyama, 2008 .

Clinical Impact of Pre-transplant Pulmonary Impairment on Survival After Allogeneic Hematopoietic Stem Cell Transplantation

K. Ohashi, H. Sakamaki, H. Akiyama, 2011, Pathology & Oncology Research.

Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia

R. Suzuki, M. Imamura, K. Kumano, 2011, International journal of hematology.

Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.

Y. Kanda, Takuhiro Yamaguchi, K. Miyamura, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene: detailed immunological function following add-back after haplo-identical transplantation.

Y. Heike, J. Mineno, I. Nukaya, 2015, Cytotherapy.